Leerink Partnrs Has Negative Outlook for Danaher Q1 Earnings

Danaher Co. (NYSE:DHR) – Equities researchers at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Danaher in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst P. Souda now expects that the conglomerate will post earnings of $1.63 per share for the quarter, down from their previous estimate of $2.02. The consensus estimate for Danaher’s current full-year earnings is $7.77 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2025 earnings at $2.43 EPS, FY2025 earnings at $7.65 EPS, Q1 2026 earnings at $1.93 EPS, Q2 2026 earnings at $1.96 EPS, Q3 2026 earnings at $2.05 EPS, Q4 2026 earnings at $2.66 EPS and FY2026 earnings at $8.60 EPS.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the firm earned $2.09 EPS.

Several other research firms have also recently issued reports on DHR. Raymond James restated a “market perform” rating on shares of Danaher in a research note on Monday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Stifel Nicolaus upped their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Robert W. Baird decreased their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, TD Cowen boosted their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Down 3.9 %

Shares of Danaher stock opened at $214.09 on Monday. The company has a 50-day simple moving average of $235.40 and a two-hundred day simple moving average of $253.09. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher has a 52-week low of $214.03 and a 52-week high of $281.70. The stock has a market capitalization of $154.64 billion, a PE ratio of 40.55, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 10.90% of the company’s stock.

Institutional Trading of Danaher

A number of institutional investors have recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC acquired a new position in Danaher in the 4th quarter valued at $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher during the 4th quarter worth $31,000. Finally, Pineridge Advisors LLC grew its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.